COMPLIANCE INFO_2019 - Laserfiche WebLink

Home Browse Search

CARDINALL SAFETY DATA SHEET ISSUED: 8/22/2 REFERENCE: BK05-TO0 006 OSHA No component of this product present at levels greater than or equal to 0.1% is identified as a carcinogen or potential carcinogen by OSHA Reproductive toxicity no data available Specific target organ toxicity - single no data available exposure Specific target organ toxicity - repeated may cause damage to organs through prolonged or repeated exposure exposure - inhalation Aspiration hazard no data available Additional information Prolonged inhalation of crystalline silica may result in silicosis, a disabling pulmonary fibrosis characterized by fibrotic changes and miliary nodules in the lungs, a dry cough, shortness of breath, emphysema, decreased chest expansion, and increased susceptibility to tuberculosis. In advanced stage, loss of appetite, pleuric pain, and total incapacity to work. Advanced silicosis may result in death due to cardiac failure or destruction of lung tissue. Crystalline silica is classified as group 1 "known to be carcinogenic to humans" by IARC and "sufficient evidence" of carcinogenicity by the NTP.,The chronic health risks are associated with respirable particles of 3-4 um over protracted periods of time. Currently, there is a limited understanding of the mechanisms of quartz toxicity, including its mechanisms for lung carcinogenicity. Additional studies are needed to determine whether the cell transforming activity of quartz is related to its carcinogenic potential. Additional information Liver- Irregularities - based on human evidence Limestone 1317-65-3 Draize test rabbit eye 750 u /24H severe Draize test rabbit skin 500 mg/24H moderate Oral rat: LD50 6450 mg/kg ACGIH IARC NTP CA Prop 65 Not listed Epidemiology No information available Teratogenicity No information available Reproductive effects No information available Mutagenicity No information available Neurotoxicity No information available Pentaerythritol tetra kis 6683-19-8 Acute toxicity - LD50 -oral - male rat > 5000 mg/kg Acute toxicity- LC50 - inahalation - male > 1.95 mg/I/4h and female rat Acute toxicity - LD50 - dermal - male and > 3160 mg/kg female rabbit Acute toxicity- LD50 - intraperitoneal - rat > 1000 mg/kg Skin corrosion - rabbit No skin irritation - 24 h Eye irritation - rabbit No eye irritation Respiratory or skin sesnsitization - guinea Does not cause skin sensitization i Germ cell mutagenicity -Ames test - S. Negative typhimurium Mutagenicity - micronucleus test- male Negative and female hamster IARC carcinogenicity No component of this product present at levels greater than or equal to 0.1% is identified as a probable, possible, or confirmed human carcinogen b IARC ACGIH No component of this product present at levels greater than or equal to 0.1% is identified as a carcinogen or potential carcinogen by ACGIH NTP No component of this product present at levels greater than or equal to 0.1% is identified as a known or anticipated carcinogen by NTP OSHA No component of this product present at levels greater than or equal to 0.1% is identified as a carcinogen or potential carcinogen by OSHA Reproductive toxicity No data available Specific target organ toxicity - single No data available exposure Specific target organ toxicity - repeated No data available exposure Aspiration hazard No data available Tris 2 4-ditert-but I hen I hos hite 31570-04-4 LD50 - oral - male and female rat -Acute > 6000 mg/kg Toxicity LD50 - dermal - male and female rat > 2000 mg/kg I Page 6 of 12